<?xml version="1.0" ?><ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.OntologyEventTranscriptSummaryOutput xmlns:ns2="local" id="2987456"><Name>GenVec Discontinues Phase 3 Clinical Trial of TNFerade(TM)</Name><Company>GenVec Inc</Company><Drugs><Drug>bevacizumab</Drug><Drug>gemcitabine</Drug><Drug>cetuximab</Drug><Drug>golnerminogene pradenovec</Drug></Drugs></ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.OntologyEventTranscriptSummaryOutput>